145 related articles for article (PubMed ID: 18848818)
21. The endocannabinoid anandamide activates pro-resolving pathways in human primary macrophages by engaging both CB
Leuti A; Fava M; Forte G; Pellegrini N; Oddi S; Scipioni L; Gomez EA; Dalli J; Maccarrone M
FASEB J; 2024 May; 38(10):e23675. PubMed ID: 38801406
[TBL] [Abstract][Full Text] [Related]
22. Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors.
Mestre L; Iñigo PM; Mecha M; Correa FG; Hernangómez-Herrero M; Loría F; Docagne F; Borrell J; Guaza C
J Neuroinflammation; 2011 Aug; 8():102. PubMed ID: 21851608
[TBL] [Abstract][Full Text] [Related]
23. [Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors].
Liu HY; Yang Q; Duan RX; Zhang YW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):430-4. PubMed ID: 18578993
[TBL] [Abstract][Full Text] [Related]
24. Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes.
Chiurchiù V; Rapino C; Talamonti E; Leuti A; Lanuti M; Gueniche A; Jourdain R; Breton L; Maccarrone M
J Immunol; 2016 Nov; 197(9):3545-3553. PubMed ID: 27694494
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
Pisanti S; Borselli C; Oliviero O; Laezza C; Gazzerro P; Bifulco M
J Cell Physiol; 2007 May; 211(2):495-503. PubMed ID: 17192847
[TBL] [Abstract][Full Text] [Related]
26. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.
Cencioni MT; Chiurchiù V; Catanzaro G; Borsellino G; Bernardi G; Battistini L; Maccarrone M
PLoS One; 2010 Jan; 5(1):e8688. PubMed ID: 20098669
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
[TBL] [Abstract][Full Text] [Related]
28. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors.
Eisenstein TK; Meissler JJ; Wilson Q; Gaughan JP; Adler MW
J Neuroimmunol; 2007 Sep; 189(1-2):17-22. PubMed ID: 17640739
[TBL] [Abstract][Full Text] [Related]
29. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.
Movsesyan VA; Stoica BA; Yakovlev AG; Knoblach SM; Lea PM; Cernak I; Vink R; Faden AI
Cell Death Differ; 2004 Oct; 11(10):1121-32. PubMed ID: 15375383
[TBL] [Abstract][Full Text] [Related]
30. Dual effect of anandamide on rat placenta nitric oxide synthesis.
Cella M; Leguizamón GF; Sordelli MS; Cervini M; Guadagnoli T; Ribeiro ML; Franchi AM; Farina MG
Placenta; 2008 Aug; 29(8):699-707. PubMed ID: 18561998
[TBL] [Abstract][Full Text] [Related]
31. Anandamide induces necrosis in primary hepatic stellate cells.
Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
[TBL] [Abstract][Full Text] [Related]
32. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition.
Nakajima Y; Furuichi Y; Biswas KK; Hashiguchi T; Kawahara K; Yamaji K; Uchimura T; Izumi Y; Maruyama I
FEBS Lett; 2006 Jan; 580(2):613-9. PubMed ID: 16406050
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the endocannabinoid system in periodontal healing.
Kozono S; Matsuyama T; Biwasa KK; Kawahara K; Nakajima Y; Yoshimoto T; Yonamine Y; Kadomatsu H; Tancharoen S; Hashiguchi T; Noguchi K; Maruyama I
Biochem Biophys Res Commun; 2010 Apr; 394(4):928-33. PubMed ID: 20233580
[TBL] [Abstract][Full Text] [Related]
34. Nonpsychotropic cannabinoid receptors regulate microglial cell migration.
Walter L; Franklin A; Witting A; Wade C; Xie Y; Kunos G; Mackie K; Stella N
J Neurosci; 2003 Feb; 23(4):1398-405. PubMed ID: 12598628
[TBL] [Abstract][Full Text] [Related]
35. Anandamide initiates Ca(2+) signaling via CB2 receptor linked to phospholipase C in calf pulmonary endothelial cells.
Zoratti C; Kipmen-Korgun D; Osibow K; Malli R; Graier WF
Br J Pharmacol; 2003 Dec; 140(8):1351-62. PubMed ID: 14645143
[TBL] [Abstract][Full Text] [Related]
36. The immunosuppressive effect of the endocannabinoid system on the inflammatory phenotypes of macrophages and mesenchymal stromal cells: a comparative study.
Ruhl T; Corsten C; Beier JP; Kim BS
Pharmacol Rep; 2021 Feb; 73(1):143-153. PubMed ID: 33026642
[TBL] [Abstract][Full Text] [Related]
37. Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.
Franklin A; Parmentier-Batteur S; Walter L; Greenberg DA; Stella N
J Neurosci; 2003 Aug; 23(21):7767-75. PubMed ID: 12944505
[TBL] [Abstract][Full Text] [Related]
38. Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis.
Chiurchiù V; Cencioni MT; Bisicchia E; De Bardi M; Gasperini C; Borsellino G; Centonze D; Battistini L; Maccarrone M
Ann Neurol; 2013 May; 73(5):626-36. PubMed ID: 23447381
[TBL] [Abstract][Full Text] [Related]
39. The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation.
Lissoni P; Tintori A; Fumagalli L; Brivio F; Messina G; Parolini D; Biondi A; Balestra A; D'Amico G
Anticancer Res; 2008; 28(6A):3743-8. PubMed ID: 19189659
[TBL] [Abstract][Full Text] [Related]
40. Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.
Krishnan G; Chatterjee N
Glia; 2012 Nov; 60(11):1629-45. PubMed ID: 22807196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
